# Clinical trials recruiting in United States: 25,297 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25,297 trials recruiting or not yet recruiting with a site in United States, as read on November 19, 2026.

## The full list

Clinical trials recruiting in United States: 25,297 rows for $332.97, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 600 rows a month: $30 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/united-states

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25,297
- Recruiting or not yet: 25,297
- Read on: November 19, 2026

## Trials

The 25 newest of 25,297, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947186 | Early Feasibility Study of a Novel Male Contraceptive Device: Safety, Usability, and Acceptability Outcomes | Indiana University | Not applicable | Recruiting | Male Contraception, Contraceptive Device, Pregnancy Prevention, Prevention of Semen Exposure During Intercourse | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947186) |
| November 18, 2026 | NCT07947082 | An Adaptive Parent-mediated Intervention to Improve Outcomes for Autistic Children | Florida International University | Not applicable | Not yet recruiting | Autism | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947082) |
| November 18, 2026 | NCT07947030 | Medical Student Acceptance and Perceptions of Augmented Reality Simulation | Stanford University | Not applicable | Not yet recruiting | Medical Education | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947030) |
| November 18, 2026 | NCT07946861 | Intramedullary Nailing for Femoral Shaft Fractures | Indiana University | Not applicable | Recruiting | Femoral Shaft Fracture | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946861) |
| November 18, 2026 | NCT07946822 | Reducing Alcohol-Involved Suicidal Ideation and Behavior | Georgia State University | Not applicable | Not yet recruiting | Heavy Episodic Drinking, Suicidal Ideation and Behavior | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946822) |
| November 18, 2026 | NCT07946705 | Effects of Akkermansia Muciniphila-Based Probiotics on Autonomic and Vascular Function | University of Minnesota | Not applicable | Not yet recruiting | Hypertension | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946705) |
| November 18, 2026 | NCT07946679 | Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure | University of Michigan | Not applicable | Not yet recruiting | Heart Failure, Heart Failure Hospitalization | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946679) |
| November 18, 2026 | NCT07946666 | A Clinical Trial to Evaluate the Effects of the Synbiotic Dual Cap® on Gastrointestinal Comfort in Adults Initiating GLP-1 or Dual-Incretin... | Epetome | Not applicable | Not yet recruiting | Gastrointestinal Discomfort, Nausea, Bloating, Constipation, Diarrhea, GLP-1 Receptor Agonist Therapy-Associated... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946666) |
| November 18, 2026 | NCT07946640 | A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety... | Driscoll's | Not applicable | Not yet recruiting | Postprandial Glycemic Response, Satiety, Blood Glucose | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946640) |
| November 18, 2026 | NCT07946627 | Everolimus Post-Bland Hepatic Artery Embolization in Patients With Neuroendocrine Tumors (NETs) With Liver Metastasis | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Neuroendocrine Tumors, Liver Metastases | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946627) |
| November 18, 2026 | NCT07946601 | Genomic ctDNA-Informed De-escalation And Neoadjuvant Chemotherapy Omission in Cystectomy | Case Comprehensive Cancer Center | Phase 2 | Not yet recruiting | Muscle Invasive Bladder Cancer (MIBC) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946601) |
| November 18, 2026 | NCT07946575 | A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy... | Trevi Therapeutics | Phase 1 | Recruiting | Healthy Participants | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946575) |
| November 18, 2026 | NCT07946536 | A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Nutritional Adequacy, Body Composition, Skin... | The Collagen Co. - GLP-1 Users | Not applicable | Not yet recruiting | Weight Management, Obesity, Nutritional Adequacy, Body Composition, Skin Health, Hunger and Satiety, GLP-1 Receptor... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946536) |
| November 18, 2026 | NCT07946471 | A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin... | The Collagen Co. - GLP-1 Users | Not applicable | Not yet recruiting | Weight Management, Body Composition, Overweight, Skin Health, Hair Health, Nail Health, Gut Health | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946471) |
| November 18, 2026 | NCT07946341 | A Study in Healthy Participants With Elevated LDL-C to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS060380 | Cascade Pharmaceuticals, Inc | Phase 1 | Not yet recruiting | MASH (Metabolic Dysfunction-Associated Steatohepatitis) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946341) |
| November 18, 2026 | NCT07946315 | Tirzepatide for the REduction of AceTazolamide in Idiopathic Intracranial Hypertension | Brigham and Women's Hospital | Phase 2 | Not yet recruiting | Idiopathic Intracranial Hypertension (IIH), Pseudotumor Cerebri, Papilledema | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946315) |
| November 18, 2026 | NCT07946302 | A Phase I Dose-Escalation Study of CUG279 in Participants With Select Advanced or Metastatic Solid Tumors | Cugene Inc. | Phase 1 | Recruiting | Advanced Solid Tumor (Phase 1) | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946302) |
| November 18, 2026 | NCT07946250 | A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or... | BrocShot Inc | Not applicable | Not yet recruiting | Reactive Skin, Blemish-Prone Skin, Hormonally Affected Skin, Acne, Rosacea, Eczema, Psoriasis, Skin Irritation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946250) |
| November 18, 2026 | NCT07946237 | Optimizing Cough Rehabilitation Through Combined Cough Skill Training and Transcutaneous Spinal Cord Stimulation | University of Florida | Not applicable | Not yet recruiting | Healthy Adult, Rehabilitation Exercise, Electric Stimulation Therapy, Cough Peak Flow, Ventilatory Function | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946237) |
| November 18, 2026 | NCT07946224 | Comparison of Breast Acoustic CT and Automated Breast Ultrasound in Women With Unilateral Untreated Breast Cancer | Stanford University | Not applicable | Not yet recruiting | Breast Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946224) |
| November 18, 2026 | NCT07946068 | Aleniglipron Renal Impairment Study | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | Phase 1 | Not yet recruiting | Renal Impairment, Severe Renal Impairment | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946068) |
| November 18, 2026 | NCT07945873 | Primary Sclerosing Cholangitis After Liver Transplant With Oral Vancomycin | Sponsor not shown (see the record) | Phase 1 | Not yet recruiting | Primary Sclerosing Cholangitis, Liver Transplant Disorder | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945873) |
| November 18, 2026 | NCT07945821 | A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors | Coherus Oncology, Inc. | Phase 1/2 | Recruiting | Solid Tumor | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945821) |
| November 18, 2026 | NCT07945730 | How a Ketogenic Diet Affects Hormones and Metabolism in Women | Ohio State University | Not applicable | Recruiting | Menstrual Cycle, Premenopausal | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945730) |
| November 18, 2026 | NCT07945704 | GLP-1 RAs and Dietary Intake and Body Composition | Ohio University | Observational | Recruiting | Glucagon-Like Peptide-1 Receptor Agonists, Metabolism, Body Composition | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945704) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Massachusetts General Hospital | Boston | 692 |
| National Institutes of Health Clinical Center | Bethesda | 618 |
| Mayo Clinic | Scottsdale | 534 |
| Memorial Sloan Kettering Cancer Center | New York | 499 |
| Washington University School of Medicine | St Louis | 472 |
| MD Anderson Cancer Center | Houston | 407 |
| University of Michigan | Ann Arbor | 400 |
| Medical University of South Carolina | Charleston | 398 |
| Northwestern University | Chicago | 374 |
| Cleveland Clinic | Cleveland | 368 |
| Dana-Farber Cancer Institute | Boston | 365 |
| Mayo Clinic in Rochester | Rochester | 363 |
| Brigham and Women's Hospital | Boston | 362 |
| Vanderbilt University Medical Center | Nashville | 360 |
| Stanford University | Palo Alto | 350 |
| University of Alabama at Birmingham | Birmingham | 345 |
| NYU Langone Health | New York | 339 |
| University of Pennsylvania | Philadelphia | 335 |
| Duke University Medical Center | Durham | 308 |
| University of California, San Francisco | San Francisco | 303 |
| University of Miami | Miami | 295 |
| Moffitt Cancer Center | Tampa | 294 |
| University of Minnesota | Minneapolis | 291 |
| Children's Hospital of Philadelphia | Philadelphia | 286 |
| Beth Israel Deaconess Medical Center | Boston | 273 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 561 |
| Phase 1 | 2,299 |
| Phase 1/2 | 1,328 |
| Phase 2 | 3,533 |
| Phase 2/3 | 269 |
| Phase 3 | 1,503 |
| Phase 4 | 1,056 |
| Not applicable | 10,171 |
| Observational | 4,577 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Breast Neoplasms | 729 |
| Neoplasms | 685 |
| Obesity | 570 |
| Prostatic Neoplasms | 529 |
| Depression | 484 |
| Carcinoma, Non-Small-Cell Lung | 471 |
| Motor Activity | 383 |
| Lung Neoplasms | 382 |
| Colorectal Neoplasms | 366 |
| Anxiety Disorders | 329 |
| Stroke | 325 |
| Neoplasm Metastasis | 311 |
| Stress Disorders, Post-Traumatic | 296 |
| Leukemia, Myeloid, Acute | 294 |
| Diabetes Mellitus, Type 2 | 287 |
| Alzheimer Disease | 277 |
| Pancreatic Neoplasms | 274 |
| Cognitive Dysfunction | 273 |
| Ovarian Neoplasms | 256 |
| Overweight | 254 |
| Multiple Myeloma | 252 |
| Pain | 251 |
| Heart Failure | 250 |
| Diabetes Mellitus | 242 |
| Parkinson Disease | 238 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| M.D. Anderson Cancer Center | 574 |
| Mayo Clinic | 555 |
| VA Office of Research and Development | 374 |
| Massachusetts General Hospital | 368 |
| Stanford University | 330 |
| Memorial Sloan Kettering Cancer Center | 313 |
| National Cancer Institute (NCI) | 308 |
| University of California, San Francisco | 293 |
| Yale University | 265 |
| Johns Hopkins University | 256 |
| University of Alabama at Birmingham | 245 |
| University of Colorado, Denver | 243 |
| NYU Langone Health | 237 |
| Washington University School of Medicine | 233 |
| Duke University | 217 |
| Emory University | 207 |
| University of Pennsylvania | 190 |
| University of Minnesota | 188 |
| The University of Texas Health Science Center, Houston | 187 |
| Wake Forest University Health Sciences | 183 |
| University of Texas Southwestern Medical Center | 178 |
| City of Hope Medical Center | 177 |
| Columbia University | 175 |
| University of Florida | 175 |
| Brigham and Women's Hospital | 169 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Medical sciences schools in the United States](https://specstream.ai/data/businesses/medical-sciences-schools/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
- [Puerto Rican restaurants in the United States](https://specstream.ai/data/businesses/puerto-rican-restaurants/united-states)
- [Speech training companies in the United States](https://specstream.ai/data/businesses/speech-training-companies/united-states)
- [Urgent care clinics in the United States](https://specstream.ai/data/businesses/urgent-care-clinics/united-states)
- [Aluminum suppliers in the United States](https://specstream.ai/data/businesses/aluminum-suppliers/united-states)
